Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1835943

AIGH Capital Management LLC

Hedge fundFiled 2026-08-07 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$1.1B
Reported positions
42
Top holdings a year, 3 yrs
+33.2%
Assets under management
$472.7M

AIGH Capital Management LLC is a hedge fund that reported 42 positions worth $1.1B in its Q2 2026 13F, filed 2026-08-07. Its largest holdings were Sandisk Corp (SNDK, 30.7%), Maxlinear Inc (MXL, 9.5%), Intel Corp (INTC, 7.9%). A portfolio copying its top holdings returned 33.2% a year over the last 3 years, against 20.4% for the S&P 500.

AIGH Capital Management LLC holdings all 42 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

AIGH Capital Management LLC 13F holdings
Stock% of 13F valueShare changeReported value
SNDKSandisk Corp30.7%-25.5%$338.8M
MXLMaxlinear Inc9.5%—$104.7M
INTCIntel Corp7.9%—$87.1M
APPSDigital Turbine Inc7.6%+33.8%$84.5M
SIMOSilicon Motion Technology Co4.3%-28.0%$48.0M
CLFDClearfield Incorporated3.6%—$40.1M
MEIMethode Electrs Inc2.9%—$31.8M
ASYSAmtech Sys Inc2.6%—$28.9M
FENCFennec Pharmaceuticals Inc2.4%+25.5%$26.7M
KYTXKyverna Therapeutics Inc.2.3%+39.8%$24.9M
NYXHNyxoah S A2.2%—$24.6M
PSNLPersonalis Inc2.1%-40.9%$23.0M
SOPHSophia Genetics SA2.1%—$22.8M
DDD3d Sys Corp Del2.0%—$22.0M
VUZIVuzix Corp1.8%+104.7%$19.6M
ABEOAbeona Therapeutics1.7%-3.6%$18.5M
ARDXArdelyx Inc1.5%—$16.3M
BDSXBiodesix Inc1.4%-10.5%$15.3M
85209E208Spruce Biosciences Inc1.2%—$13.5M
CSTLCastle Biosciences Inc1.2%-7.7%$13.0M
VNDAVanda Pharmaceuticals Inc1.1%-25.7%$12.5M
PTHSPelthos Therapeutics Inc0.8%—$9.3M
PYPDPolypid Ltd0.7%-5.6%$7.6M
VSTMVerastem Inc0.7%-3.6%$7.4M
BWENBroadwind Energy Inc Com New0.5%—$5.6M
LIDRAeye Inc0.5%—$5.6M
KIDSOrthopediatrics Corp0.5%—$5.2M
APYXApyx Medical Corporation0.5%+2.1%$5.1M
IPWRIdeal Pwr Inc0.4%-24.3%$4.8M
TLPHTalphera Inc0.4%-1.3%$4.7M
TYGOTigo Energy Inc0.4%-72.7%$4.6M
WATTEnergous Corp0.4%-15.3%$4.4M
RNXTRenovorx Inc0.4%+18.9%$4.3M
RELLRichardson Electrs Ltd0.3%—$3.8M
NRXSNeuraxis Inc0.3%+30.0%$3.8M
COYACoya Therapeutics Inc0.3%-35.2%$3.7M
INVEInve Technologies Inc0.3%+254.1%$3.7M
ELUTElutia Inc0.2%-25.0%$2.6M
APREAprea Therapeutics Inc0.1%+0.0%$815K
BFRIBiofrontera Inc0.1%-19.2%$700K
QNRXQuoin Pharmaceuticals Ltd0.0%+37.3%$339K
NNBRNn Inc0.0%—$41K

What AIGH Capital Management LLC bought and sold in Q2 2026, against Q1 2026.

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year
+115.4% /yr
S&P 500 +20.1%
3 years
+33.2% /yr
S&P 500 +20.4%
5 years
+15.2% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$1.1B42
Q1 2026$488.3M40
Q4 2025$338.3M31
Q3 2025$285.6M34
Q2 2025$213.1M34
Q1 2025$192.7M38
Q4 2024$265.7M36
Q3 2024$213.6M38
Q2 2024$204.9M36
Q1 2024$207.5M41
Q4 2023$252.8M39
Q3 2023$211.1M46

Questions about AIGH Capital Management LLC's portfolio

What stocks does AIGH Capital Management LLC own?

AIGH Capital Management LLC's latest 13F, for Q2 2026 and filed Aug 7, 2026, lists 42 positions worth $1.1B. The largest are Sandisk Corp (SNDK) at 30.7%, Maxlinear Inc (MXL) at 9.5%, Intel Corp (INTC) at 7.9%, Digital Turbine Inc (APPS) at 7.6% and Silicon Motion Technology Co (SIMO) at 4.3%.

What did AIGH Capital Management LLC buy last quarter?

In Q2 2026, AIGH Capital Management LLC added a new position in Maxlinear Inc (MXL), a new position in Intel Corp (INTC), a new position in Clearfield Incorporated (CLFD), a new position in Methode Electrs Inc (MEI), a new position in Amtech Sys Inc (ASYS), Inve Technologies Inc (INVE) (+254.1% shares), Vuzix Corp (VUZI) (+104.7% shares) and Kyverna Therapeutics Inc. (KYTX) (+39.8% shares), compared with its Q1 2026 filing.

What did AIGH Capital Management LLC sell last quarter?

In Q2 2026, AIGH Capital Management LLC sold all of Zebra Technologies Corporati (ZBRA), sold all of Nlight Inc (LASR), sold all of Generac Hldgs Inc (GNRC), sold all of Regal Rexnord Corporation (RRX), sold all of Larimar Therapeutics Inc (LRMR), Tigo Energy Inc (TYGO) (-72.7% shares), Personalis Inc (PSNL) (-40.9% shares) and Coya Therapeutics Inc (COYA) (-35.2% shares), compared with its Q1 2026 filing.

How has AIGH Capital Management LLC's portfolio performed?

A portfolio copying AIGH Capital Management LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +33.2% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +115.4% against +20.1%. Over 5 years: +15.2% a year against +11.6%.

When is AIGH Capital Management LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. AIGH Capital Management LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does AIGH Capital Management LLC manage?

AIGH Capital Management LLC reported $472.7M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $1.1B.